A detailed history of Connors Investor Services Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Connors Investor Services Inc holds 71,697 shares of HRMY stock, worth $2.44 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
71,697
Previous 73,000 1.78%
Holding current value
$2.44 Million
Previous $2.31 Million 14.35%
% of portfolio
0.17%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 25, 2025

SELL
$26.76 - $38.05 $34,868 - $49,579
-1,303 Reduced 1.78%
71,697 $1.98 Million
Q2 2025

Jul 30, 2025

BUY
$27.94 - $35.91 $5,755 - $7,397
206 Added 0.28%
73,000 $2.31 Million
Q1 2025

May 12, 2025

BUY
$32.18 - $40.46 $3,282 - $4,126
102 Added 0.14%
72,794 $2.42 Million
Q4 2024

Feb 14, 2025

BUY
$31.86 - $41.49 $2.32 Million - $3.02 Million
72,692 New
72,692 $2.5 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Connors Investor Services Inc Portfolio

Follow Connors Investor Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connors Investor Services Inc with notifications on news.